Abvc Biopharma (ABVC) Interest Coverage Ratio (2010 - 2026)
Abvc Biopharma's (ABVC) quarterly Interest Coverage Ratio came in at 0.72 in Q1 2026, down 586.97% YoY from 0.15 in Q1 2025, and up 88.75% on a QoQ basis from 6.43 in Q4 2025.
Abvc Biopharma (ABVC) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has 16 years of Interest Coverage Ratio data on file, last reported at 0.72 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 586.97% year-over-year to 0.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.69 (down 849.75% YoY) and the FY2025 annual result came in at 17.2, down 201.82% from the prior year.
- Interest Coverage Ratio grew to 0.72 in Q1 2026, from 6.43 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.38 in Q4 2023 to a low of 141.84 in Q1 2022.
- A 5-year average of 19.22 and a median of 0.47 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 101.62% — and 2025, when it plunged 1432.79%.
- Tracing ABVC's Interest Coverage Ratio over 5 years: stood at 23.3 in 2022, then jumped by 101.62% to 0.38 in 2023, then plunged by 332.33% to 0.88 in 2024, then slumped by 633.56% to 6.43 in 2025, then surged by 88.75% to 0.72 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.72 (Q1 2026), 6.43 (Q4 2025), and 7.14 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Abvc Biopharma | 23.34 Mn | 23.34 Mn | - | -18.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10 |
| Mar 31, 2026 | -0.72 |
| Dec 31, 2025 | -6.43 |
| Sep 30, 2025 | -7.14 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.11 |
| Dec 31, 2024 | -0.88 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | -0.45 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | -0.34 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -23.30 |
| Sep 30, 2022 | -5.73 |
| Jun 30, 2022 | -138.69 |
| Mar 31, 2022 | -141.84 |
| Dec 31, 2021 | -1,034.69 |
| Sep 30, 2021 | -94.59 |